艾昆纬 IQV 深 沪
已收盘 02-06 16:00:00 美东时间
187.49
+6.530
+3.61%
华盛通- 最 高190.09
- 今 开183.12
- 成交量 344.30万股
- 最 低 182.77
- 昨 收 180.96
- 总市值 319.30亿
- 52周最高 247.045
- 市盈率 静 23.91
- 换手率 2.02%
- 52周最低 134.645
- 委 比 -17.65%
- 总股本 1.70亿
- 历史最高 285.61
- 量 比 1.15
- 振 幅 4.05%
- 历史最低 81.79
- 每 手 1
- 风险率 29.46%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多财报速睇 | 艾昆纬 2025财年Q4营收43.64亿美元，同比增长10.3%；归母净利润5.14亿美元，同比增长17.6%
华盛资讯2月7日讯，艾昆纬公布2025财年Q4业绩，公司Q4营收43.64亿美元，同比增长10.3%，归母净利润5.14亿美元，同比增长17.6%。
02-07 04:51
Barclays Maintains Equal-Weight on IQVIA Hldgs, Lowers Price Target to $210
Barclays analyst Luke Sergott maintains IQVIA Hldgs (NYSE:IQV) with a Equal-Weight and lowers the price target from $230 to $210.
02-06 23:26
UPDATE 1-IQVIA backs AI strategy as analysts question impact on business
UPDATE 1-IQVIA backs AI strategy as analysts question impact on business Rewrites throughout, adds share movement in paragraph 3, CEO comments in paragraph 4,5 & 7, analyst comment in paragraph 8 By Kamal Choudhury and Sahil Pandey Feb 5 (Reuters) - Healthcare data and clinical research provider IQ
02-06 00:52
BUZZ-U.S. STOCKS ON THE MOVE-OneSpaWorld, IMUNON, Cigna
BUZZ-U.S. STOCKS ON THE MOVE-OneSpaWorld, IMUNON, Cigna Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The S&P 500 slid to near two-week lows and the Nasdaq sank to its lowest level
02-05 23:44
BUZZ-IQVIA falls after forecasting annual profit below estimates
BUZZ-IQVIA falls after forecasting annual profit below estimates ** Shares of contract research firm IQVIA Holdings IQV.N fall 10% to $184 premarket ** Co expects 2026 adj. EPS of $12.55–$12.85, below analysts’ estimate of $12.95 – data compiled by LSEG ** Co forecasts Q1 2026 adj. EPS of $2.77–$2.8
02-05 23:25
IQVIA Hldgs Q4 Earnings Report: What Investors Need to Know
The Q4 earnings report for IQVIA Hldgs (NYSE:IQV) was released on Thursday, Feb...
02-05 20:06
ANALYSIS-Novo Nordisk risks weight-loss price war as discount pressures deepen
ANALYSIS-Novo Nordisk risks weight-loss price war as discount pressures deepen Analysts, investors fear price war in obesity drug market Novo cut Wegovy prices under Trump pressure, to win cash-pay patients Shares sink more than 15% on 2026 warning CEO: short-term price pain for volume, sales gains
02-04 22:29
诺和诺德、礼来迈入新时代，减肥药市场销售潜力遇冷
华尔街长期以来预测全球减肥药市场未来十年规模将达 1500 亿美元，而如今这一预期的确定性大幅降低：诺和诺德与礼来的胰高血糖素样肽 - 1（GLP-1）类减...
02-02 20:54
